Search for a command to run...
Articles tagged with #patentlaw
The Federal Circuit’s August 29, 2025, decision in Hyatt v. Stewart finally brings a very long patent dispute to an end. The court confirmed, once again, that the United States Patent and Trademark Office (USPTO) can use prosecution laches to block p...
The Federal Circuit’s July 2025 decision in Acorda Therapeutics, Inc. v. Alkermes PLC offers a clear lesson in jurisdictional strategy. Although the dispute revolved around post-expiration patent royalties, the court never reached the merits. Instead...
The Federal Circuit’s decision in Laboratory Corp. of America Holdings v. Qiagen Sciences, LLC, No. 23-2350 (Fed. Cir. Aug. 13, 2025), serves as a pointed reminder that jury verdicts, particularly in technically complex patent cases, remain subject t...
The Federal Circuit’s decision in Laboratory Corp. of America Holdings v. Qiagen Sciences, LLC (Aug. 13, 2025) is a strong reminder that jury verdicts in patent cases do not always survive appeal especially when they stretch claim language or rely on...
In July 2025, the Federal Circuit delivered an important ruling in Janssen Pharmaceuticals, Inc. v. Teva Pharmaceuticals USA, Inc. The case centered on U.S. Patent No. 9,439,906, which protects specific dosing regimens for long-acting injectable form...
On July 14, 2025, the Federal Circuit issued an important ruling in Shockwave Medical, Inc. v. Cardiovascular Systems, Inc. This case centered on U.S. Patent No. 8,956,371, which relates to angioplasty catheters using electrohydraulic lithotripsy (EH...
